rdf:type |
|
lifeskim:mentions |
umls-concept:C0014257,
umls-concept:C0024109,
umls-concept:C0026336,
umls-concept:C0033085,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0529793,
umls-concept:C0542341,
umls-concept:C1135196,
umls-concept:C1292733,
umls-concept:C1801960,
umls-concept:C2709248
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-3-16
|
pubmed:abstractText |
Pulmonary hypertension as a frequent complication of left heart disease (PH-LHD) is characterized by lung endothelial dysfunction and vascular remodeling. Although PH-LHD contributes to morbidity and mortality in heart failure, established therapies for PH-LHD are lacking. We tested the effect of chronic sildenafil treatment in an experimental model of PH-LHD.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1941-3297
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
198-206
|
pubmed:dateRevised |
2011-10-27
|
pubmed:meshHeading |
pubmed-meshheading:21216837-Administration, Oral,
pubmed-meshheading:21216837-Animals,
pubmed-meshheading:21216837-Antihypertensive Agents,
pubmed-meshheading:21216837-Cyclic GMP,
pubmed-meshheading:21216837-Cyclic Nucleotide Phosphodiesterases, Type 5,
pubmed-meshheading:21216837-Disease Models, Animal,
pubmed-meshheading:21216837-Endothelium, Vascular,
pubmed-meshheading:21216837-Heart Failure, Diastolic,
pubmed-meshheading:21216837-Hypertension, Pulmonary,
pubmed-meshheading:21216837-Hypertrophy, Left Ventricular,
pubmed-meshheading:21216837-Hypertrophy, Right Ventricular,
pubmed-meshheading:21216837-Lung,
pubmed-meshheading:21216837-Male,
pubmed-meshheading:21216837-Nitric Oxide,
pubmed-meshheading:21216837-Phosphodiesterase 5 Inhibitors,
pubmed-meshheading:21216837-Piperazines,
pubmed-meshheading:21216837-Pulmonary Artery,
pubmed-meshheading:21216837-Purines,
pubmed-meshheading:21216837-Rats,
pubmed-meshheading:21216837-Rats, Sprague-Dawley,
pubmed-meshheading:21216837-Sulfones,
pubmed-meshheading:21216837-Time Factors,
pubmed-meshheading:21216837-Vascular Resistance,
pubmed-meshheading:21216837-Vasodilation,
pubmed-meshheading:21216837-Ventricular Function, Left,
pubmed-meshheading:21216837-Ventricular Function, Right
|
pubmed:year |
2011
|
pubmed:articleTitle |
Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
|
pubmed:affiliation |
Keenan Research Centre at the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|